Cytosorbents
CTSO
#10821
Rank
โ‚ฌ13.88 M
Marketcap
4,41ย โ‚ฌ
Share price
-0.41%
Change (1 day)
675.45%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -โ‚ฌ16.03 Million

According to Cytosorbents's latest financial reports the company's current earnings are โ‚ฌ37.21 Million. In 2025 the company made an earning of -โ‚ฌ7.82 Million, an increase over its 2024 earnings that were of -โ‚ฌ20.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ16.03 Million105.09%
2025 -โ‚ฌ7.82 Million-62.16%
2024 -โ‚ฌ20.65 Million-22.49%
2023 -โ‚ฌ26.64 Million-13.52%
2022 -โ‚ฌ30.81 Million34.04%
2021 -โ‚ฌ22.99 Million182.17%
2020 -โ‚ฌ8.15 Million-55.97%
2019 -โ‚ฌ18.5 Million14.17%
2018 -โ‚ฌ16.2 Million95.14%
2017 -โ‚ฌ8.31 Million-22.32%
2016 -โ‚ฌ10.69 Million39.1%
2015 -โ‚ฌ7.69 Million-12.89%
2014 -โ‚ฌ8.82 Million89%
2013 -โ‚ฌ4.67 Million26.65%
2012 -โ‚ฌ3.69 Million-26.02%
2011 -โ‚ฌ4.99 Million-288.45%
2010 โ‚ฌ2.64 M-4.17%
2009 โ‚ฌ2.75 M-287.19%
2008 -โ‚ฌ1.48 Million-47.12%
2007 -โ‚ฌ2.79 Million41.78%
2006 -โ‚ฌ1.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
โ‚ฌ3.21 B-19,085.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
โ‚ฌ0.70 B-4,277.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
โ‚ฌ50.42 M-398.19%๐Ÿ‡บ๐Ÿ‡ธ USA